Abstract: Techniques are disclosed for obtaining data using memory timing characteristics. In some embodiments, a physical unclonable function is used to obtain the data. In various embodiments, a computer system programs a timing parameter of a memory accessible by the computer system to a value that is outside of a specified operable range for the timing parameter. In various embodiments, the computer system performs one or more memory operations to a least a portion of the memory and detects a pattern of errors in the portion of the memory. In some embodiments, the computer system generates a response dependent on the pattern of errors. The response may be used to identify the computer system.

Abstract: Techniques for facilitating conversion of an application from a block-based persistence model to a byte-based persistence model are provided. In one embodiment, a computer system can receive source code of the application and automatically identify data structures in the source code that are part of the application's semantic persistent state. The computer system can then output a list of data types corresponding to the identified data structures.

Abstract: The present invention relates to a natural sweetening composition comprising Luo Han Guo concentrate in an amount of 0.1 to 95% by weight and use in beverage, food, pharmaceutical, oral, dietetic, veterinary or tobacco products thereof.

Abstract: The present invention relates to improvements made in the blister advancement mechanism of dry powder inhaler devices. A dry powder inhaler device mechanism comprising an actuator plate and a transmission wheel is provided.

Abstract: The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.

Abstract: Techniques are disclosed for obtaining data using memory timing characteristics. In some embodiments, a physical unclonable function is used to obtain the data. In various embodiments, a computer system programs a timing parameter of a memory accessible by the computer system to a value that is outside of a specified operable range for the timing parameter. In various embodiments, the computer system performs one or more memory operations to a least a portion of the memory and detects a pattern of errors in the portion of the memory. In some embodiments, the computer system generates a response dependent on the pattern of errors. The response may be used to identify the computer system.

Abstract: The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.

Abstract: The present invention relates to a natural sweetening composition comprising Luo Han Guo concentrate in an amount of 0.1 to 95% by weight and use in beverage, food, pharmaceutical, oral, dietetic, veterinary or tobacco products thereof.

Abstract: Techniques for facilitating conversion of an application from a block-based persistence model to a byte-based persistence model are provided. In one embodiment, a computer system can receive source code of the application and automatically identify data structures in the source code that are part of the application's semantic persistent state. The computer system can then output a list of data types corresponding to the identified data structures.

Abstract: The present invention relates to a dry powder inhaler device comprising a body having a guide surface formed on an inner surface thereof, a trigger having a socket with a shape complementing the guide surface, and a spring, characterized by comprising at least one retaining element (8) positioned on the inner surface (1) of the body diagonally across the spring (6) to enable the trigger (5) to perform a stable axial displacement and a mechanism check or quality control to be made as one of the parts of the device (7) body is not closed or assembled yet.

Abstract: The present invention relates to a natural sweetening composition comprising apple concentrate having a median particle size (d50) greater than 100 ?m and Luo Han Guo concentrate having a median particle size (d50) greater than 1 ?m and use in beverage, food, pharmaceutical, oral, dietetic, veterinary or tobacco products thereof.

Abstract: The present invention relates to a natural sweetening composition comprising Luo Han Guo concentrate having a median particle size (d50) greater than 1 ?m and use in beverage, food, pharmaceutical, oral, dietetic, veterinary or tobacco products thereof.

Abstract: The present invention relates to a natural sweetening composition comprising concentrates of apple and Luo Han Guo. This composition to provide the advantages of being healthy and natural, not increasing the glycemic index, production simplicity, cost-efficient and sweeter taste because of the synergy between concentrates of apple and Luo Han Guo.

Abstract: A pharmaceutical combination comprising sitagliptin or a pharmaceutically acceptable salt thereof in combination with a sulfonylurea.

Abstract: Parallelism-aware scheduling of memory requests of threads in shared memory controllers. Parallel scheduling is achieved by prioritizing threads that already have requests being serviced in the memory banks. A first algorithm prioritizes requests of the last-scheduled thread that is currently being serviced. This is accomplished by tracking the thread that generated the last-scheduled request (if the request is still being serviced), and then scheduling another request from the same thread if there is an outstanding ready request from the same thread. A second algorithm prioritizes the requests of all threads that are currently being serviced. This is accomplished by tracking threads that have at least one request currently being serviced in the banks, and assigning the highest priority to these threads in the scheduling decisions. If there are no outstanding requests from any thread having requests that are being serviced, the algorithm defaults back to a baseline scheduling algorithm.

Abstract: This invention relates to novel pharmaceutical compositions for inhalation comprising separately, sequentially or together, drugs having amine in the form of a dry powder in admixture with a pharmaceutically acceptable carrier, other than lactose, and its use in the treatment of respiratory condition selected from asthma and chronic obstructive pulmonary disease (COPD) and other obstructive airways diseases. More particulary, the invention relates to pharmaceutical composition for inhalation further comprising a ternary component. In addition, the present invention relates to novel pharmaceutical composition for inhalation based on combinations of long acting muscarinic antagonists, long acting beta agonists, short acting beta-2 agonists, corticosteroids or a combination of two or more of them.

Abstract: The present invention relates to pharmaceutical powder compositions used by means of inhalation devices. The present invention more particularly relates to a filling method which provides an ideal volume and density for the compositions used in inhalation devices and delivers a desired amount of a fine particle dose to the patient.

Abstract: The present invention relates to a pharmaceutical combination of flurbiprofen or a pharmaceutically acceptable salt thereof, glucosamine or a pharmaceutically acceptable salt thereof and capsaicin or a pharmaceutically acceptable salt thereof. Particularly, the present invention relates to a pharmaceutical combination for use in the treatment of pain and inflammatory symptoms associated with joint and cartilage disorders, especially with osteoarthritis and rheumatoid arthritis.

Abstract: The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.

Abstract: The present invention relates to a method for increasing meat and milk production in livestock, wherein olanzapine or a pharmaceutically acceptable salt, solvate, polymorph, or a racemic mixture thereof is administered to the livestock.